Bionano Genomics, Inc. (BNGO) Insider Trading
Directors, officers and holders of more than 10% of BNGO report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 53 transactions on file: 2 with code P, 0 with code S and 48 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 4, 2026 | Luderer Albert | Interim Chief Executive | P Purchase | 4,000 | $1.21 | $4,845 |
| Aug 21, 2026 | Luderer Albert | Interim Chief Executive | P Purchase | 4,000 | $1.22 | $4,860 |
| Aug 3, 2026 | OLDAKOWSKI MARK | Chief Operating Officer | A Award | 15,000 | Not measured | Not measured |
| Aug 3, 2026 | Dixon Jonathan V. | General Counsel | A Award | 15,000 | Not measured | Not measured |
| Aug 3, 2026 | Adamchak Mark | Principal Accounting Officer | A Award | 5,000 | Not measured | Not measured |
| Aug 3, 2026 | Hastie Alex Reid | Chief Scientific Officer | A Award | 54,000 | Not measured | Not measured |
| Jun 3, 2026 | Dixon Jonathan V. | General Counsel | F Tax Payment | 24 | $1.30 | $31 |
| Jun 3, 2026 | Adamchak Mark | Principal Accounting Officer | F Tax Payment | 7 | $1.30 | $9 |
| Jun 3, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | F Tax Payment | 24 | $1.30 | $31 |
| Jun 3, 2026 | OLDAKOWSKI MARK | Chief Operating Officer | F Tax Payment | 27 | $1.30 | $35 |
| May 14, 2026 | TWOMEY CHRISTOPHER J | Director | A Award | 9,149 | Not measured | Not measured |
| May 14, 2026 | Linney Yvonne | Director | A Award | 9,149 | Not measured | Not measured |
| May 14, 2026 | Vuori Kristiina MD | Director | A Award | 9,149 | Not measured | Not measured |
| May 14, 2026 | BARKER DAVID L | Director | A Award | 9,149 | Not measured | Not measured |
| May 14, 2026 | Rajkovic Aleksandar | Director | A Award | 9,149 | Not measured | Not measured |
| Feb 17, 2026 | Adamchak Mark | Principal Accounting Officer | F Tax Payment | 3 | $1.10 | $3 |
| Feb 17, 2026 | Holmlin R. Erik | PRESIDENT AND CEO | F Tax Payment | 51 | $1.10 | $56 |
| Feb 17, 2026 | OLDAKOWSKI MARK | Chief Operating Officer | F Tax Payment | 20 | $1.10 | $22 |
| Feb 17, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | F Tax Payment | 18 | $1.10 | $20 |
| Feb 17, 2026 | Dixon Jonathan V. | General Counsel | F Tax Payment | 6 | $1.10 | $7 |
| Feb 2, 2026 | Holmlin R. Erik | PRESIDENT AND CEO | A Award | 69,484 | Not measured | Not measured |
| Feb 2, 2026 | Adamchak Mark | Principal Accounting Officer | A Award | 10,890 | Not measured | Not measured |
| Feb 2, 2026 | Chaubey Alka | CHIEF MEDICAL OFFICER | A Award | 27,737 | Not measured | Not measured |
| Feb 2, 2026 | Dixon Jonathan V. | General Counsel | A Award | 26,117 | Not measured | Not measured |
| Feb 2, 2026 | OLDAKOWSKI MARK | Chief Operating Officer | A Award | 27,737 | Not measured | Not measured |
| Sep 11, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | F Tax Payment | 59 | $4.06 | $240 |
| Sep 11, 2025 | Chaubey Alka | CHIEF MEDICAL OFFICER | F Tax Payment | 51 | $4.06 | $207 |
| Jun 11, 2025 | Luderer Albert | Interim Chief Executive | A Award | 2,775 | Not measured | Not measured |
| Jun 11, 2025 | Vuori Kristiina MD | Director | A Award | 2,775 | Not measured | Not measured |
| Jun 11, 2025 | TWOMEY CHRISTOPHER J | Director | A Award | 2,775 | Not measured | Not measured |
| Jun 11, 2025 | Rajkovic Aleksandar | Director | A Award | 2,775 | Not measured | Not measured |
| Jun 11, 2025 | Mamuszka Hannah | Director | A Award | 2,775 | Not measured | Not measured |
| Jun 11, 2025 | BARKER DAVID L | Director | A Award | 2,775 | Not measured | Not measured |
| Jun 11, 2025 | Linney Yvonne | Director | A Award | 2,775 | Not measured | Not measured |
| Jun 3, 2025 | Holmlin R. Erik | PRESIDENT AND CEO | F Tax Payment | 75 | $3.69 | $277 |
| Jun 3, 2025 | Adamchak Mark | Principal Accounting Officer | F Tax Payment | 7 | $3.69 | $26 |
| Jun 3, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | F Tax Payment | 27 | $3.69 | $100 |
| Jun 3, 2025 | Dixon Jonathan V. | General Counsel | F Tax Payment | 25 | $3.69 | $92 |
| Jun 3, 2025 | Chaubey Alka | CHIEF MEDICAL OFFICER | F Tax Payment | 24 | $3.69 | $89 |
| Mar 14, 2025 | Holmlin R. Erik | PRESIDENT AND CEO | F Tax Payment | 198 | $3.47 | $687 |
| Mar 14, 2025 | Dixon Jonathan V. | General Counsel | A Award | 6,559 | Not measured | Not measured |
| Mar 14, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | A Award | 6,966 | Not measured | Not measured |
| Mar 14, 2025 | Holmlin R. Erik | PRESIDENT AND CEO | A Award | 17,449 | Not measured | Not measured |
| Mar 14, 2025 | Adamchak Mark | Principal Accounting Officer | A Award | 3,029 | Not measured | Not measured |
| Mar 14, 2025 | Chaubey Alka | CHIEF MEDICAL OFFICER | A Award | 6,966 | Not measured | Not measured |
| Feb 15, 2025 | Chaubey Alka | CHIEF MEDICAL OFFICER | F Tax Payment | 18 | $5.73 | $103 |
| Feb 15, 2025 | Dixon Jonathan V. | General Counsel | F Tax Payment | 6 | $5.73 | $34 |
| Feb 15, 2025 | Holmlin R. Erik | PRESIDENT AND CEO | F Tax Payment | 51 | $5.73 | $292 |
| Feb 15, 2025 | Adamchak Mark | Principal Accounting Officer | F Tax Payment | 4 | $5.73 | $23 |
| Feb 15, 2025 | OLDAKOWSKI MARK | Chief Operating Officer | F Tax Payment | 20 | $5.73 | $115 |
The full Form 4 history is on the BNGO company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.